Jane Street Group LLC Trims Position in Addus HomeCare Co. (NASDAQ:ADUS)

Jane Street Group LLC decreased its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 52.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,273 shares of the company’s stock after selling 9,018 shares during the quarter. Jane Street Group LLC’s holdings in Addus HomeCare were worth $1,101,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Quarry LP bought a new position in shares of Addus HomeCare during the third quarter worth $28,000. Quest Partners LLC bought a new position in Addus HomeCare during the second quarter valued at $31,000. Farther Finance Advisors LLC lifted its position in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the last quarter. Sandia Investment Management LP bought a new position in Addus HomeCare during the second quarter valued at $58,000. Finally, GAMMA Investing LLC lifted its holdings in shares of Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock worth $124,000 after acquiring an additional 191 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the topic of several recent analyst reports. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. JMP Securities assumed coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Stephens raised their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $133.67.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $126.28 on Tuesday. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.12. The stock has a market capitalization of $2.29 billion, a P/E ratio of 28.90, a P/E/G ratio of 2.11 and a beta of 1.01. The company’s 50-day simple moving average is $125.55 and its 200-day simple moving average is $125.57.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same period last year, the business earned $1.03 EPS. The company’s revenue was up 7.1% compared to the same quarter last year. On average, research analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Insider Activity

In other news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This represents a 18.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.